Account
Inquiry
Tirzepatide 15mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic research applications. The compound features a 39-amino acid peptide structure with specific modifications that enhance its stability and biological activity.
This research-grade peptide demonstrates significant potential in glucose regulation and weight management studies. The 15mg dosage represents a standard research concentration, with purity verified through HPLC analysis. Each batch undergoes rigorous quality control testing to ensure consistency and reliability for scientific applications.
As a research chemical, tirzepatide 15mg is provided in lyophilized form for enhanced stability. The product is intended for laboratory use only, with proper handling procedures required. Researchers should note that clinical applications require additional formulation steps beyond the scope of this basic research material.
Our manufacturing facility maintains GMP-compliant production standards for all peptide compounds. The tirzepatide 15mg is synthesized using advanced solid-phase peptide synthesis methods, followed by comprehensive purification and analytical verification. This ensures researchers receive material of the highest quality for their investigations.
